Literature DB >> 11829467

Eukaryotic cell determination of ExoS ADP-ribosyltransferase substrate specificity.

Jennifer E Fraylick1, Elizabeth A Rucks, Deanne M Greene, Timothy S Vincent, Joan C Olson.   

Abstract

Exoenzyme S (ExoS) ADP-ribosylates multiple low-molecular-mass G- (LMMG-) proteins in vitro. Identification of the in vivo substrate specificity of ExoS has been hindered by its bacterial contact delivery into eukaryotic cells and difficulties in identifying ADP-ribosylated proteins within cells. Two-dimensional electrophoresis comparisons of substrate modifications by ExoS in vitro to that following bacterial translocation into HT-29 epithelial cells identified Ras, Ral, and Rab proteins and Rac1 as in vivo substrates of ExoS ADPRT activity. Cellular fractionation studies identified a relationship between membrane association and efficiency of substrate modification. Moreover, Rac and Cdc42 relocalized to the membrane in response to ExoS. Comparisons of substrate modification to time of exposure to ExoS identified a progression of substrate modification, with Ras, RalA, and Rab5 modified first, followed by Rab8 and 11, then Rab7 and Rac1. The data support that intrinsic properties of LMMG-proteins and their subcellular localization are determinants of bacterially translocated ExoS substrate selectivity. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829467     DOI: 10.1006/bbrc.2002.6402

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Examination of the coordinate effects of Pseudomonas aeruginosa ExoS on Rac1.

Authors:  Claudia L Rocha; Elizabeth A Rucks; Deanne M Vincent; Joan C Olson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Characterization of an ExoS Type III translocation-resistant cell line.

Authors:  Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function.

Authors:  Grace Soong; Dane Parker; Mariah Magargee; Alice S Prince
Journal:  J Bacteriol       Date:  2007-12-28       Impact factor: 3.490

4.  Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.

Authors:  Jinghua Jia; Yanping Wang; Lei Zhou; Shouguang Jin
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

5.  Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.

Authors:  Vincent T Lee; Roger S Smith; Burkhard Tümmler; Stephen Lory
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities.

Authors:  L Garrity-Ryan; S Shafikhani; P Balachandran; L Nguyen; J Oza; T Jakobsen; J Sargent; X Fang; S Cordwell; M A Matthay; J N Engel
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages.

Authors:  Claudia L Rocha; Jenifer Coburn; Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.

Authors:  Maria L Henriksson; Charlotta Sundin; Anna L Jansson; Ake Forsberg; Ruth H Palmer; Bengt Hallberg
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

9.  Exoenzyme S ADP-ribosylates Rab5 effector sites to uncouple intracellular trafficking.

Authors:  Nathan C Simon; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-10-07       Impact factor: 3.441

Review 10.  The role of type III secretion system 2 in Vibrio parahaemolyticus pathogenicity.

Authors:  Hyeilin Ham; Kim Orth
Journal:  J Microbiol       Date:  2012-11-04       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.